Prevents melanin production by binding to the enzyme and inhibitingits activity
doi:10.1111/j.1365-2125.1980.tb01812.x
Formulation, treatment goals, individual health factors and the providers recommendations all matter
POMC, PCSK1, and LEPR Deficiency and BBS (Pediatric Patients Aged 2 to less than 6 Years) The safety of IMCIVREE was evaluated in one 52-week, open-label clinical trial of 12 patients aged 2 to less than 6 years with obesity due to POMC, PCSK1, or LEPR deficiency with POMC, PCSK1, or LEPRgenes that are interpreted as pathogenic, likely pathogenic, or of uncertain significance, or obesity due to BBS (Trial 5) [see Clinical Studies (14.4)]
Timing and Dosage for Best Results While you can take them together, the timing and way you take them can influence how well they are absorbed